STS Circle at Harvard
[image.png]
Alberto Cambrosio
McGill, Social Studies of Medicine

on
When drugs cross disease lines. (Dis)assembling clinical research in 
post-genomic oncology


Monday, March 24
12:15-2:00 pm
Room 100F, Pierce Hall, 29 Oxford Street

[image.png]

Lunch is provided if you RSVP.
Please RSVP to 
sts<mailto:[email protected]>@hks.harvard.edu<mailto:[email protected]> 
by 5pm Wednesday, March 19.

Abstract: Grounded in an empirical analysis of the development of medical 
oncology from the 1960s-present (and, in particular, of the activities of 
emergent organizations, such as Cooperative Oncology Groups and, more recently, 
clinical cancer research consortia), the paper explores the mutually 
constitutive relation between epistemic and organizational innovation. In 
particular, it will examine how, confronted with a ‘similar’ issue—the 
promotion of stronger interactions between pre-clinical and clinical work—1960 
oncologists and their turn-of-the-century colleagues developed quite different 
solutions, in spite of powerful path-dependency effects. These different 
outcomes cannot be reduced to the actors’ strategies or to a political 
sociology of science that neglects the content of bio-clinical practices. They 
correspond to two distinctive socio-technical networks that can be better 
understood by focusing on their core actant, namely ‘regimens’ (a notion 
partially borrowed from the oncology field), and the sequence of framings and 
overflows they engender. While STS has traditionally rejected the distinction 
between social and cognitive aspects of practices—an approach exemplified by 
the co-productionist program—social scientists in other domains continue to 
debate whether organizational innovation leads to cognitive innovation or vice 
versa, and are still caught in the opposition between configurational (static) 
and dynamic analysis. Regimens provide a heuristic alternative to these 
dichotomies. It remains to be seen whether this approach can be applied to 
domains other than oncology, thus bypassing the opposition between objects 
(entities) and practices.


Biography:  A professor at McGill University’s Department of Social Studies of 
Medicine since 1990, Alberto Cambrosio most recent project examines ‘genomics 
in action’, i.e., as applied to concrete instances of medical work. His most 
recent book (Cancer on Trial: Oncology as a New Style of Practice, University 
of Chicago Press, 2012/pbk 2014 co-authored with Peter Keating) argues that 
clinical trials do not boil down to a mere technology; they rise to the level 
of a ‘new style of practice’ insofar as they generate novel, distinctive ways 
of producing and assessing medical knowledge. This work builds on a previous 
book (Biomedical Platforms, MIT Press, 2003/pbk 2006, co-authored with Peter 
Keating) that analyzed the transformation of medicine into biomedicine and its 
consequences since the end of World War II. Other publications include 
Exquisite Specificity. The Monoclonal Antibody Revolution (Oxford University 
Press, 2005, co-authored with Peter Keating).




A complete list of STS Circle at Harvard events can be found on our website:
http://www.hks.harvard.edu/sts/events/sts_circle/
Follow us on Facebook: STS@Harvard<http://www.facebook.com/HarvardSTS>




_______________________________________________


<<inline: image.png>>

_______________________________________________
Sci-tech-public mailing list
[email protected]
http://mailman.mit.edu/mailman/listinfo/sci-tech-public

Reply via email to